Identify undiagnosed patients with kidney disease and track their care to improve health outcomes and avoid large, unpredictable medical bills.
Minimize the cost of care by knowing which members are high-risk and driving early intervention.
Succeed in this shifting space by deploying precisely-targeted care delivery to the patients who need it most.
"We see the partnership between Rogosin and pulseData as critical to our future. We believe the current CKD project is the beginning of many collaborative projects to come and we look forward to the continued growth and success of our relationship."
— Dr. Jeffrey Silberzweig, Chief Medical Officer of The Rogosin Institute
We partner closely with your providers to reduce the burden of chronic disease across your population by letting them know exactly who is at risk of acute events and which of their care workflows are working.
Article discussing the impact of the COVID-19 outbreak and patients with CKD and ESRD.
Our thoughts on the recently announced Final Interoperability Ruling
pulseData has crunched the numbers to help nephrology practices understand how the KCC models will impact on revenue
